📱 Now on iPhone — live scores, valuations & alerts on the go
Beauty Health Co (SKIN)
Healthcare
Model Divergence
low
mixed
$9.94
Updated: 2026-10-31
Next earnings: Nov 4, after close (est.)
As of October 31, 2026, TradeApes rates Beauty Health Co (SKIN) 48 out of 100 (Mixed); valuation verdict: Model Divergence.
Financial Strength
57
Mixed
Relative Value
25
Overvalued
Capital Allocation
43
Weak
Risk Management
68
Healthy
The market price implies growth our normalized base can't support, so we don't publish a single fair-value figure for SKIN.
Key Findings
What's working
-
+
Margins expanding 29.3 points — costs growing slower than sales
-
+
Operating margin expanded 29.3 points over about three years — improving profitability
-
+
Generates cash — not dependent on raising money
What to watch
-
−
Operating profit covers interest -0.7× over — thin cover
-
−
Earnings yield -0.2% (P/E about —) — no earnings to value
-
−
Revenue growth about -7% a year (YoY and 3-yr blend) — sales are shrinking
AI-written analysis
The full Beauty Health Co (SKIN) analysis
Writing the SKIN analysis…0s
Save your watchlist
Create a free account to keep tracking these stocks with full analysis.
TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor.
The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.